Literature DB >> 11473080

Impact of diabetes on long-term survival after acute myocardial infarction: comparability of risk with prior myocardial infarction.

K J Mukamal1, R W Nesto, M C Cohen, J E Muller, M Maclure, J B Sherwood, M A Mittleman.   

Abstract

OBJECTIVE: To determine the effect of diabetes on long-term survival after acute myocardial infarction and to compare its effect with that of a previous myocardial infarction. RESEARCH DESIGN AND METHODS: In a prospective cohort study, we followed 1,935 patients hospitalized with a confirmed acute myocardial infarction at 45 U.S. medical centers between 1989 and 1993, as part of the Determinants of Myocardial Infarction Onset Study. Trained interviewers performed chart reviews and face-to-face interviews with all patients. We analyzed survival using Cox proportional hazards regression to control for potentially confounding factors.
RESULTS: Of the 1,935 patients, 320 (17%) died during a mean follow-up of 3.7 years. A total of 399 patients (21%) had previously diagnosed diabetes. Diabetes was associated with markedly higher total mortality in unadjusted (hazard ratio [HR] 2.4; 95% CI 1.9-3.0) and adjusted (1.7; 1.3-2.1) analyses. The magnitude of the effect of diabetes was identical to that of a previous myocardial infarction. The effect of diabetes was not significantly modified by age, smoking, household income, use of thrombolytic therapy, type of hypoglycemic treatment, or duration of diabetes, but the risk associated with diabetes was higher among women than men (adjusted HRs 2.7 vs. 1.3, P = 0.01).
CONCLUSIONS: Diabetes is associated with markedly increased mortality after acute myocardial infarction, particularly in women. The increase in risk is of the same magnitude as a previous myocardial infarction and provides further support for aggressive treatment of coronary risk factors among diabetic patients.

Entities:  

Mesh:

Year:  2001        PMID: 11473080     DOI: 10.2337/diacare.24.8.1422

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  61 in total

1.  [Tackling lipaemia in diabetes mellitus in primary care].

Authors:  C Llor Vilà
Journal:  Aten Primaria       Date:  2003       Impact factor: 1.137

2.  Trends in cardiovascular risk factors among patients with coronary heart disease: results from the EUROASPIRE I, II, and III surveys in the Münster region.

Authors:  Christof Prugger; Jan Heidrich; Jürgen Wellmann; Ralf Dittrich; Stefan-Martin Brand; Ralph Telgmann; Günter Breithardt; Holger Reinecke; Hans Scheld; Peter Kleine-Katthöfer; Peter U Heuschmann; Ulrich Keil
Journal:  Dtsch Arztebl Int       Date:  2012-04-27       Impact factor: 5.594

Review 3.  The treatment of obesity in cardiac rehabilitation.

Authors:  Philip A Ades; Patrick D Savage; Jean Harvey-Berino
Journal:  J Cardiopulm Rehabil Prev       Date:  2010 Sep-Oct       Impact factor: 2.081

4.  Diabetes, diabetes severity, and coronary heart disease risk equivalence: REasons for Geographic and Racial Differences in Stroke (REGARDS).

Authors:  Favel L Mondesir; Todd M Brown; Paul Muntner; Raegan W Durant; April P Carson; Monika M Safford; Emily B Levitan
Journal:  Am Heart J       Date:  2016-08-12       Impact factor: 4.749

5.  Coronary heart disease prevention in clinical practice: are patients with diabetes special? Evidence from two studies of older men and women.

Authors:  J R Emberson; P H Whincup; D A Lawlor; D Montaner; S Ebrahim
Journal:  Heart       Date:  2005-04       Impact factor: 5.994

6.  Differences in trends in estimated incidence of myocardial infarction in non-diabetic and diabetic people: Monitoring Trends and Determinants on Cardiovascular Diseases (MONICA)/Cooperative Health Research in the Region of Augsburg (KORA) registry.

Authors:  A Icks; T Dickhaus; A Hörmann; M Heier; G Giani; B Kuch; C Meisinger
Journal:  Diabetologia       Date:  2009-07-15       Impact factor: 10.122

7.  The prognostic value of different glucose abnormalities in patients with acute myocardial infarction treated invasively.

Authors:  Michal Mazurek; Jacek Kowalczyk; Radoslaw Lenarczyk; Teresa Zielinska; Agnieszka Sedkowska; Patrycja Pruszkowska-Skrzep; Andrzej Swiatkowski; Beata Sredniawa; Oskar Kowalski; Lech Polonski; Krzysztof Strojek; Zbigniew Kalarus
Journal:  Cardiovasc Diabetol       Date:  2012-06-28       Impact factor: 9.951

Review 8.  Diabetic dyslipidaemia: from basic research to clinical practice.

Authors:  M-R Taskinen
Journal:  Diabetologia       Date:  2003-05-28       Impact factor: 10.122

9.  Sustained cardiomyocyte apoptosis and left ventricular remodelling after myocardial infarction in experimental diabetes.

Authors:  T Bäcklund; E Palojoki; A Saraste; A Eriksson; P Finckenberg; V Kytö; P Lakkisto; E Mervaala; L-M Voipio-Pulkki; M Laine; I Tikkanen
Journal:  Diabetologia       Date:  2004-01-13       Impact factor: 10.122

10.  Emerging role for antioxidant therapy in protection against diabetic cardiac complications: experimental and clinical evidence for utilization of classic and new antioxidants.

Authors:  Michael F Hill
Journal:  Curr Cardiol Rev       Date:  2008-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.